List of works by Martin Lagging

A model explaining the correlations between IL28B-related genotypes, hepatitis C virus genotypes, and viral RNA levels.

scientific article published on 29 September 2010

A non-invasive fibrosis score predicts treatment outcome in chronic hepatitis C virus infection

scientific article published in January 2008

A novel fibrosis index comprising a non-cholesterol sterol accurately predicts HCV-related liver cirrhosis

scientific article

A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel

scientific article published on July 2011

Acute exacerbation of chronic hepatitis B: yet another incentive to commence universal infant immunization even in low endemic areas

scientific article published on 01 January 2008

Are FoxP3(+) cells involved in hyporesponsiveness to interferon/ribavirin therapy in chronic hepatitis C?

scientific article published in February 2011

Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: a randomized phase II trial

scientific article published on 30 June 2006

Chronic hepatitis C in Sweden: genotype distribution over time in different epidemiological settings

scientific article published on 01 January 1999

Chronic hepatitis C in Swedish subjects receiving opiate substitution therapy--factors associated with advanced fibrosis.

scientific article published on 20 February 2014

Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers

scientific article published in July 2005

Comparison of serum hepatitis C virus RNA and core antigen concentrations and determination of whether levels are associated with liver histology or affected by specimen storage time.

scientific article

Core mutations, IL28B polymorphisms and response to peginterferon/ribavirin treatment in Swedish patients with hepatitis C virus genotype 1 infection ⬇️

scientific article

Do variations in the ITPA gene determine the risk of hepatitis C virus relapse?

scientific article published in January 2014

Dynamic tailoring of treatment durations improves efficiency of hepatitis C treatment with pegylated interferon and ribavirin.

scientific article published on 16 October 2012

Early determination of hepatitis C virus RNA may help to decide the duration of therapy for chronic hepatitis C virus genotype 2/3 infection

scientific article published on 28 December 2010

Early quantification of HCV core antigen may help to determine the duration of therapy for chronic genotype 2 or 3 HCV infection

scientific article published on 24 November 2011

Editorial: ribavirin continues to play a role in treatment with direct-acting antivirals for hepatitis C virus-infected patients with decompensated cirrhosis

scientific article published in December 2017

Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with pre

scientific article

Elevated antibody reactivity to measles virus NCORE protein among patients with multiple sclerosis and their healthy siblings with intrathecal oligoclonal immunoglobulin G production

scientific article published on 20 June 2014

Evaluation of QuickVue, a rapid enzyme immunoassay test for the detection of serum antibodies to Helicobacter pylori

scientific article published on 01 May 1993

Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C.

scientific article

HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project).

scientific article published on 3 July 2007

Hepatitis C treatment response kinetics and impact of baseline predictors

scientific article published in June 2011

Hepatitis E virus genotype 3 is associated with gallstone-related disease

scientific article published on 25 September 2019

IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon/ribavirin for chronic hepatitis C genotype 1.

scientific article published on 13 January 2011

IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C.

scientific article published on 25 February 2011

IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C.

scientific article published on 28 March 2011

IP-10 predicts the first phase decline of HCV RNA and overall viral response to therapy in patients co-infected with chronic hepatitis C virus infection and HIV

scientific article

IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection

scientific article

Immunoregulatory role of secreted glycoprotein G from respiratory syncytial virus

scientific article published in June 2001

Impact of IL28B SNPs on therapeutic outcome and liver histology differs between hepatitis C virus genotypes

scientific article published on June 2012

Impact of IL28B-related single nucleotide polymorphisms on liver histopathology in chronic hepatitis C genotype 2 and 3

scientific article (publication date: 2012)

Impact of Il28b-related single nucleotide polymorphisms on liver transient elastography in chronic hepatitis C infection

scientific article

Impact of disease severity on outcome of antiviral therapy in treatment-naïve patients with chronic hepatitis C.

scientific article published in May 2007

Impact of donor histology on survival following liver transplantation for chronic hepatitis C virus infection: a Scandinavian single-center experience

scientific article published on 27 March 2012

Impact of hepatic steatosis on viral kinetics and treatment outcome during antiviral treatment of chronic HCV infection

scientific article published in January 2007

Impact of obesity on the bioavailability of peginterferon-α2a and ribavirin and treatment outcome for chronic hepatitis C genotype 2 or 3

scientific article (publication date: 2012)

Impact of soluble CD26 on treatment outcome and hepatitis C virus-specific T cells in chronic hepatitis C virus genotype 1 infection

scientific article

Indeterminate third-generation hepatitis C recombinant immunoblot assay and HCV RNA analysis: isolated reactivity against NS5 associated with HCV viraemia in clinical patients but not blood donors

scientific article published in January 2005

Inosine Triphosphate Pyrophosphatase Dephosphorylates Ribavirin Triphosphate and Reduced Enzymatic Activity Potentiates Mutagenesis in Hepatitis C Virus

scientific article published on 12 September 2018

Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection

scientific article

Interleukin 28B gene variation at rs12979860 determines early viral kinetics during treatment in patients carrying genotypes 2 or 3 of hepatitis C virus

scientific article published in June 2011

International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C.

scientific article published in August 2005

Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection

scientific article published in June 1999

Intrahepatic mRNA levels of SOCS1 and SOCS3 are associated with cirrhosis but do not predict virological response to therapy in chronic hepatitis C.

scientific article published on 14 November 2012

Is HCV RNA analysis at day 7 cost-effective in deciding the duration of therapy in chronic HCV genotype 2/3 infection?

scientific article published on 11 November 2010

Long-term effects of treatment and response in patients with chronic hepatitis C on quality of life. An international, multicenter, randomized, controlled study

scientific article

Look-back screening for the identification of transfusion-induced hepatitis C virus infection in Sweden

scientific article published on 07 March 2011

Lower risk of multiple sclerosis in patients with chronic hepatitis C: a nationwide population-based registry study

scientific article published on 31 May 2019

Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection

scientific article

Monitoring treatment response by the hepatitis C virus core antigen assay

scientific article published in March 2005

Monitoring virological responses to interferon-ribavirin and interferon monotherapy of chronic hepatitis C re-treated due to relapse or non-response

scientific article published in January 2001

Neonatal transfusion-transmitted hepatitis C virus infection following a pre-seroconversion window-phase donation in Sweden

scientific article published on 9 June 2013

Neutralization of pseudotyped vesicular stomatitis virus expressing hepatitis C virus envelope glycoprotein 1 or 2 by serum from patients

scientific article

No need to discontinue hepatitis C virus therapy at the time of liver transplantation

scientific article published on 22 February 2019

Nonresponder patients with hepatitis C virus genotype 2/3 infection: a question of low systemic interferon concentrations?

scientific article published in February 2010

Nosocomial transmission of HCV in a cardiology ward during the window phase of infection: an epidemiological and molecular investigation.

scientific article published on January 2002

Observed and calculated interleukin-28B genotype frequencies in hepatitis C virus infection

scientific article published in November 2010

PRO-C3: a new and more precise collagen marker for liver fibrosis in patients with chronic hepatitis C.

scientific article

Predicting treatment outcome following 24 weeks peginterferon alpha-2a/ribavirin therapy in patients infected with HCV genotype 1: utility of HCV-RNA at day 0, day 22, day 29, and week 6.

scientific article published in January 2007

Progression of fibrosis in untreated patients with hepatitis C virus infection

scientific article published in April 2002

Randomized comparison of 12 or 24 weeks of peginterferon alpha-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection

scientific article

Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimens.

scientific article

Reply: To PMID 24519039.

scientific article published on 24 September 2014

Response Prediction and Treatment Tailoring for Chronic Hepatitis C Virus Genotype 1 Infection

scientific article

Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms

scientific article

Retreatment with peg-interferon and ribavirin in patients with chronic hepatitis C virus genotype 2 or 3 infection with prior relapse

scientific article published on July 2013

Ribavirin plasma concentration is a predictor of sustained virological response in patients treated for chronic hepatitis C virus genotype 2/3 infection

scientific article published in April 2011

Sofosbuvir/velpatasvir for the treatment of HCV: excellent results from a phase-3, open-label study in Russia and Sweden

scientific article published on 30 November 2018

Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients

scientific article published in December 2002

Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C

scientific article

The impact of fibrosis and steatosis on early viral kinetics in HCV genotype 1-infected patients treated with Peg-IFN-alfa-2a and ribavirin

scientific article published on 22 December 2011

The novel ss469415590 variant predicts virological response to therapy in patients with chronic hepatitis C virus type 1 infection.

scientific article published on 5 December 2013

The relation of 25-hydroxy vitamin D concentrations to liver histopathology, seasonality and baseline characteristics in chronic hepatitis C virus genotype 2 or 3 infection

scientific article published on 21 August 2020

The relationship between IFNL4 genotype and the rate of fibrosis in hepatitis C patients

scientific article published on 03 September 2019

Treatment for chronic hepatitis C in a cohort of opiate substitution therapy recipients in three Swedish cities - completion rates and efficacy.

scientific article published on May 2014

Treatment of hepatitis C virus infection for adults and children: updated Swedish consensus guidelines 2017.

scientific article published in March 2018

Treatment of hepatitis C virus infection in adults and children: updated Swedish consensus recommendations

scientific article published on 16 April 2012

Treatment of hepatitis C virus infection: updated Swedish Consensus recommendations

scientific article

Variants of the inosine triphosphate pyrophosphatase gene are associated with reduced relapse risk following treatment for HCV genotype 2/3.

scientific article

Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection

scientific article published on August 2008

Paulina is supported by:

About Paulina

Help